已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Endovascular treatment of the subclavian artery aneurysm in high-risk patient - a single-center experience

医学 锁骨下动脉 外科 无症状的 动脉瘤 支架 放射科 胸痛
作者
Ivan Marjanović,Aleksandar Tomić,Nebojša Marić,Danijela Pecarski,Momir Šarac,Dragana Paunović,Sinisa Rusovic
出处
期刊:Vojnosanitetski Pregled [Military Health Department, Ministry of Defance, Serbia]
卷期号:73 (10): 941-944 被引量:10
标识
DOI:10.2298/vsp150420091m
摘要

We present our first experience with endovascular treatment of 6 subclavian artery aneurysms (SAA) occurring in five male and one female patient. All patients, in our studies, according to ASA classification were high risk for open repair of SAA. The etiology of the all aneurysms was atherosclerosis degeneration of the artery. Two aneurysms were of intrathoracic location, then the other were extrathoracic. Symptoms related to subclavian artery aneurysms were present in two patients, compression and chest pain in one, and hemorrhage shock in second, while the remaining patients were asymptomatic. We preferred the Viabhan endoprosthesis for endovascular repair in 5 cases. In one patient with ruptured of subclavian artery aneurysm who was high-risk for open repair we made combined endovascular procedure. First at all, we covered the origin of left subclavian artery with thoracic stent graft and after that we put two coils in proximal part of subclavian artery. There was no operative mortality, and the early patency rate was 100%. The follow-up period was from 3 months to 3 years. During this period, one patient died of heart failure and one patient required endovascular reoperation due to endoleak type I. Endovascular treatment is recommended for all patients with subclavian artery aneurysm whenever this is possible due to anatomical reasons especially in high-risk patient with intrathoracic localization of aneurysm, to prevent potential complications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
顺利醉蓝完成签到 ,获得积分10
3秒前
在水一方应助QY采纳,获得10
3秒前
海棠拾月完成签到 ,获得积分10
7秒前
小神仙完成签到 ,获得积分10
7秒前
田様应助老六采纳,获得10
9秒前
zhangbinyuan完成签到,获得积分10
9秒前
yjh123应助玥宝宝采纳,获得10
9秒前
10秒前
挚智完成签到 ,获得积分10
10秒前
呆萌井完成签到,获得积分10
10秒前
11秒前
ww发布了新的文献求助10
15秒前
zzt发布了新的文献求助10
15秒前
15秒前
随机科研完成签到,获得积分10
15秒前
丸子完成签到,获得积分10
16秒前
RHJ完成签到 ,获得积分10
17秒前
欣逸完成签到,获得积分10
17秒前
YZChen完成签到,获得积分10
18秒前
18秒前
ke发布了新的文献求助10
19秒前
HuLL完成签到 ,获得积分10
19秒前
在kyt前苦苦等了几千年完成签到,获得积分10
19秒前
合适尔风完成签到,获得积分10
20秒前
时尚梦易完成签到,获得积分10
20秒前
默默板凳完成签到,获得积分10
22秒前
扶摇完成签到,获得积分10
22秒前
沉默完成签到,获得积分10
23秒前
默默板凳发布了新的文献求助10
25秒前
zzt完成签到,获得积分10
26秒前
26秒前
Samuel应助爱听歌的咸鱼采纳,获得20
26秒前
27秒前
小猫钓鱼灯完成签到 ,获得积分10
27秒前
春和景明完成签到,获得积分10
27秒前
28秒前
张雨婷完成签到,获得积分10
29秒前
北克完成签到 ,获得积分10
29秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Direct and Iterative Linear System Solvers 500
Plato's Parmenides. A Constructive Reading 500
Vander's Renal Physiology第10版 500
Poetics of Cognition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7304228
求助须知:如何正确求助?哪些是违规求助? 8922331
关于积分的说明 18901146
捐赠科研通 6967711
什么是DOI,文献DOI怎么找? 3212078
关于科研通互助平台的介绍 2380918
邀请新用户注册赠送积分活动 2189356